Design, synthesis, and characterization of a dual modality positron emission tomography and fluorescence imaging agent for monoclonal antibody tumor-targeted imaging.
about
Key factors influencing ADME properties of therapeutic proteins: A need for ADME characterization in drug discovery and developmentToward preparation of antibody-based imaging probe libraries for dual-modality positron emission tomography and fluorescence imaging.Targeting HER2: a report on the in vitro and in vivo pre-clinical data supporting trastuzumab as a radioimmunoconjugate for clinical trials.Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of diseaseMultimodality imaging probes: design and challenges.Detection of Cancer Metastases with a Dual-labeled Near-Infrared/Positron Emission Tomography Imaging AgentImproved speciation characteristics of PEGylated indocyanine green-labeled Panitumumab: revisiting the solution and spectroscopic properties of a near-infrared emitting anti-HER1 antibody for optical imaging of cancer.In Vitro and In Vivo Pre-Clinical Analysis of a F(ab')(2) Fragment of Panitumumab for Molecular Imaging and Therapy of HER1 Positive CancersInert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targets.The Role of Molecular Imaging in Drug Delivery.A novel bifunctional maleimido CHX-A'' chelator for conjugation to thiol-containing biomoleculesNovel Strategy for Preparing Dual-Modality Optical/PET Imaging Probes via Photo-Click Chemistry.Cetuximab: preclinical evaluation of a monoclonal antibody targeting EGFR for radioimmunodiagnostic and radioimmunotherapeutic applications.Evaluation of platinum chemotherapy in combination with HER2-targeted α-particle radiationNoninvasive imaging of cell-mediated therapy for treatment of cancer.Multimodality imaging: beyond PET/CT and SPECT/CT.Preclinical evaluation of a monoclonal antibody targeting the epidermal growth factor receptor as a radioimmunodiagnostic and radioimmunotherapeutic agent.Applications for site-directed molecular imaging agents coupled with drug delivery potential.Multimodal radio- (PET/SPECT) and fluorescence imaging agents based on metallo-radioisotopes: current applications and prospects for development of new agents.A sialic acid-targeted near-infrared theranostic for signal activation based intraoperative tumor ablation.Bimodal imaging probes for combined PET and OI: recent developments and future directions for hybrid agent developmentN-Terminal dual protein functionalization by strain-promoted alkyne-nitrone cycloaddition.Molecular imaging with optics: primer and case for near-infrared fluorescence techniques in personalized medicine.Chemoenzymatic strategy for the synthesis of site-specifically labeled immunoconjugates for multimodal PET and optical imaging.Synthesis and characterization of a glycine-modified heptamethine indocyanine dye for in vivo cancer-targeted near-infrared imaging.Synthesis and characterization of a novel near-infrared fluorescent probe for applications in imaging A549 cells.Synthesis of a Fluorescently Labeled 68Ga-DOTA-TOC Analog for Somatostatin Receptor Targeting.
P2860
Q28082880-FA99EE33-ABE8-4270-A6CD-945851B5EFB6Q33464006-2533AC8D-859C-411C-B941-9DE35576C2E2Q33661325-57E800C9-55C5-4804-9886-253EF4B4EEB1Q33870879-0A81EE17-5C70-4DF9-96C8-89CB33FEFCD2Q33884695-9787E9FF-5DEB-4AD4-BA37-E1054FE2F4F6Q34111208-1003EB7F-2040-4C63-8F3C-64FE383DFC84Q34785833-170CF25F-6183-4F4B-BA91-01F5FCDAC1D1Q35162293-2369EF94-4468-4C50-97AB-D109E395B409Q35650596-95742923-7D89-4D7D-B65F-17956ADD8BD0Q36108266-33906E15-146A-4A84-84DF-B72979774F1BQ36593424-DA4A36F3-E4FA-4365-990A-F711ABBE271BQ36913628-29438F93-1C0A-4F67-94B8-8DD4A3128550Q36982489-BCFD7D5B-FC3B-4754-BCEA-A9467F81ED4FQ37025617-B5279C99-C3FA-4000-A336-32690C0D7B6BQ37181560-8C6FC09B-BF18-46DE-AB3F-B7A67A7FE3B1Q37327184-1715A7DB-DD4B-475F-BEB0-59C77C19B121Q37395272-00EBB89F-B2FB-4A51-BB8C-229AACFD2A33Q37529871-A0D4FF94-1214-404D-94B3-F43991E9BBFDQ37827710-F1B470BB-A255-4985-8F66-C850C65DF6C1Q40980205-63BAB38C-3D8A-4BBC-A58D-CD768C42EB78Q41448000-8A5856E0-18EE-4015-B83B-FE409C916E3AQ41926494-D57610F0-B866-46C0-BCF8-9CB3B4B31E84Q42269073-1BD182FE-7F2E-4B6E-8B5A-9A5C57670DA7Q42556439-E7F16C63-CFE5-42DE-AE65-7FBCC672A663Q43808139-BE763910-131E-4F9C-BC3F-BDDA925ACB6DQ50222420-4A049CB4-4EE1-43B0-9F12-0DEE4C942FD8Q50520715-D5B99393-A7B2-4070-9B9F-DE8DBCE087C7
P2860
Design, synthesis, and characterization of a dual modality positron emission tomography and fluorescence imaging agent for monoclonal antibody tumor-targeted imaging.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Design, synthesis, and charact ...... tibody tumor-targeted imaging.
@ast
Design, synthesis, and charact ...... tibody tumor-targeted imaging.
@en
type
label
Design, synthesis, and charact ...... tibody tumor-targeted imaging.
@ast
Design, synthesis, and charact ...... tibody tumor-targeted imaging.
@en
prefLabel
Design, synthesis, and charact ...... tibody tumor-targeted imaging.
@ast
Design, synthesis, and charact ...... tibody tumor-targeted imaging.
@en
P2093
P2860
P356
P1476
Design, synthesis, and charact ...... tibody tumor-targeted imaging.
@en
P2093
Andrew J Gunn
C Andrew Boswell
Diane E Milenic
Kwamena Baidoo
Martin W Brechbiel
Peter L Choyke
P2860
P304
P356
10.1021/JM070657W
P407
P577
2007-08-29T00:00:00Z